Inhibition of Drp1–Filamin Protein Complex Prevents Hepatic Lipid Droplet Accumulation by Increasing Mitochondria–Lipid Droplet Contact
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25105446 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Kohei Ariyoshi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan. Hauptthemen laut MEDLINE: Dynamins, Lipid Droplets, Liver, Dihydropyridines. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JST, CREST, JPSP, KAKENHI, Grant-in-Aid for Scientific Research on Innovative Areas(A) "Sulfur biology".
Abstract (Originalsprache)
Lipid droplet (LD) accumulation in hepatocytes is one of the major symptoms associated with fatty liver disease. Mitochondria play a key role in catabolizing fatty acids for energy production through β-oxidation. The interplay between mitochondria and LD assumes a crucial role in lipid metabolism, while it is obscure how mitochondrial morphology affects systemic lipid metabolism in the liver. We previously reported that cilnidipine, an already existing anti-hypertensive drug, can prevent pathological mitochondrial fission by inhibiting protein–protein interaction between dynamin-related protein 1 (Drp1) and filamin, an actin-binding protein. Here, we found that cilnidipine and its new dihydropyridine (DHP) derivative, 1,4-DHP, which lacks Ca2+ channel-blocking action of cilnidipine, prevent the palmitic acid-induced Drp1–filamin interaction, LD accumulation and cytotoxicity of human hepatic HepG2 cells. Cilnidipine and 1,4-DHP also suppressed the LD accumulation accompanied by reducing mitochondrial contact with LD in obese model and high-fat diet-fed mouse livers. These results propose that targeting the Drp1–filamin interaction become a new strategy for the prevention or treatment of fatty liver disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
- Laboratory of Prophylactic Pharmacology, Osaka Metropolitan University Graduate School of Veterinary Science, Osaka 598-8531, Japan.
- National Institute for Physiological Sciences (NIPS), National Institutes of Natural Sciences (NINS), Okazaki 444-8787, Japan.
- Exploratory Research Center on Life and Living Systems (ExCELLS), National Institutes of Natural Sciences (NINS), Okazaki 444-8787, Japan.
- Department of Physiological Sciences, School of Life Science, The Graduate University for Advanced Studies (SOKENDAI), Okazaki 444-8787, Japan.
ORCID-Profile: Yuri Kato, Tomoya Ito, Yasu-Taka Azuma, Akiyuki Nishimura, Motohiro Nishida
Förderung
- JST, CREST
- JPSP, KAKENHI
- Grant-in-Aid for Scientific Research on Innovative Areas(A) "Sulfur biology"
- JPMJCR2024
- JSPS KAKENHI
- Grant-in-Aid for Scientific Research on Innovative Areas(A) “Sulfur biology”
Zitieren
APA
Ariyoshi, K., Nishiyama, K., Kato, Y., Mi, X., Ito, T., Azuma, Y. T., Nishimura, A., & Nishida, M. (2024). Inhibition of Drp1–Filamin Protein Complex Prevents Hepatic Lipid Droplet Accumulation by Increasing Mitochondria–Lipid Droplet Contact. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25105446
Vancouver
Ariyoshi K, Nishiyama K, Kato Y, Mi X, Ito T, Azuma YT, et al. Inhibition of Drp1–Filamin Protein Complex Prevents Hepatic Lipid Droplet Accumulation by Increasing Mitochondria–Lipid Droplet Contact. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25105446
BibTeX
@article{Ariyoshi2024,
author = {Ariyoshi, Kohei and Nishiyama, Kazuhiro and Kato, Yuri and Mi, Xinya and Ito, Tomoya and Azuma, Yasu-Taka and Nishimura, Akiyuki and Nishida, Motohiro},
title = {Inhibition of Drp1–Filamin Protein Complex Prevents Hepatic Lipid Droplet Accumulation by Increasing Mitochondria–Lipid Droplet Contact},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25105446}
}
EUVIMED